CoChat

Evolution of Pseudomonas aeruginosa Pathogenicity: From Acute to Chronic Infections

Oliver, Antonio, Mena, Ana, Maciá, María D. · 2014 · Evolutionary Biology of Bacterial and Fungal Pathogens
Cited by 8

The DOI matches its Crossref record, with a small difference in title or year; 6 of the 6 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/9781555815639.ch36

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 85

  1. Alonso, 1999, Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin, Environ. Microbiol., 1:, 421, 10.1046/j.1462-2920.1999.00052.x · DOI · Paper page
  2. Bagge, 2004, Dynamics and spatial distribution of β-lactamase expression in Pseudomonas aeruginosa biofilms, Antimicrob. Agents Chemother., 48:, 1168, 10.1128/AAC.48.4.1168-1174.2004 · DOI · Paper page
  3. Barbieri, 2004, Pseudomonas aeruginosa ExoS and ExoT, Rev. Physiol. Biochem. Pharmacol., 152:, 79, 10.1007/s10254-004-0031-7 · DOI · Paper page
  4. Blazquez, 2003, Hypermutation as a factor contributing to the acquisition of antimicrobial resistance, Clin. Infect. Dis., 37:, 1201, 10.1086/378810 · DOI · Paper page
  5. Boles, 2004, Self-generated diversity produces “insurance effects” in biofilm communities, Proc. Natl. Acad. Sci. USA., 101:, 16630, 10.1073/pnas.0407460101 · DOI · Paper page
  6. Bragonzi, 2005, Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model, J. Infect. Dis., 192:, 410, 10.1086/431516 · DOI
  7. Chopra, 2003, The role of mutators in the emergence of antibiotic-resistant bacteria, Drug Resist. Updates., 6:, 137, 10.1016/S1368-7646(03)00041-4 · DOI · Paper page
  8. Ciofu, 2005, Ocurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflamation, Antimicrob. Agents Chemother., 49:, 2276, 10.1128/AAC.49.6.2276-2282.2005 · DOI · Paper page
  9. Comolli, 1999, Pseudomonas aeruginosa gene products PilT and PilU are required for cytotoxicity in vitro and virulence in a mouse model of acute pneumonia, Infect. Immun., 67:, 3625, 10.1128/IAI.67.7.3625-3630.1999 · DOI · Paper page
  10. Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science., 284:, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
  11. Cox, 1974, Selection for high mutation rates in chemostats, Genetics., 77:, 169, 10.1093/genetics/77.2.169 · DOI · Paper page
  12. Davies, 1998, The involvement of cell-to-cell signals in the development of a bacterial biofilm, Science., 280:, 295, 10.1126/science.280.5361.295 · DOI · Paper page
  13. Ernst, 1999, Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa, Science., 286:, 1561, 10.1126/science.286.5444.1561 · DOI · Paper page
  14. Evans, 1996, Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa, Eur. Respir. J., 9:, 1601, 10.1183/09031936.96.09081601 · DOI · Paper page
  15. Feldman, 1998, Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection, Infect. Immun., 66:, 43, 10.1128/IAI.66.1.43-51.1998 · DOI · Paper page
  16. Funchain, 2001, Amplification of mutator cells in a population as a result of horizontal transfer, J. Bacteriol., 183:, 3737, 10.1128/JB.183.12.3737-3741.2001 · doi:10.1128/jb.183.12.3737-3741.2001
  17. Gibson, 2003, Pathophysiology and management of pulmonary infections in cystic fibrosis, Am. J. Respir. Crit. Care Med., 168:, 918, 10.1164/rccm.200304-505SO · DOI · Paper page
  18. Giraud, 2001, Cost and benfits of high mutation rates: adaptive evolution of bacteria in the mouse gut, Science., 291:, 2606, 10.1126/science.1056421 · DOI · Paper page
  19. Goldman, 1997, Human β-defensin-1 is a salt sensitive antibiotic in lung that is inactivated in cystic fibrosis, Cell., 88:, 553, 10.1016/S0092-8674(00)81895-4 · DOI · Paper page
  20. Govan, 1996, Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia, Microbiol. Rev., 60:, 539, 10.1128/MMBR.60.3.539-574.1996 · doi:10.1128/mmbr.60.3.539-574.1996 · Paper page
  21. Gutiérrez, 2004, Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients, Antimicrob. Agents Chemother., 48:, 3573, 10.1128/AAC.48.9.3573-3575.2004 · DOI · Paper page
  22. Hanage, 2004, Molecular Microbiology: Diagnostic Principles and Practise
  23. Hancock, 1983, Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains defficient in lipopolysaccharide O side chains, Infect. Immun., 42:, 170, 10.1128/IAI.42.1.170-177.1983 · DOI · Paper page
  24. Hatch, 1998, Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 42:, 974, 10.1128/AAC.42.4.974 · DOI · Paper page
  25. Häußler, 1999, Small colony variants of Pseudomonas aeruginosa in cystic fibrosis, Clin. Infect. Dis., 29:, 621, 10.1086/598644 · DOI · Paper page
  26. He, 2004, The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes, Proc. Natl. Acad. Sci. USA., 101:, 2530, 10.1073/pnas.0304622101 · DOI · Paper page
  27. Henwood, 2001, Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British society for antimicrobial chemotherapy disc susceptibility test, J. Antimicrob. Chemother., 47:, 789, 10.1093/jac/47.6.789 · doi:10.1093/jac/47.6.789
  28. Hill, 2000, Markers of airway inflammation in patients with stable chronic bronchitis, Am. J. Med., 109:, 288, 10.1016/S0002-9343(00)00507-6 · DOI · Paper page
  29. Hogardt, 2007, Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis, J. Infect. Dis., 195:, 70, 10.1086/509821 · DOI
  30. Imundo, 1995, Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface, Proc. Natl. Acad. Sci. USA., 92:, 3019, 10.1073/pnas.92.7.3019 · DOI · Paper page
  31. Kiewitz, 2000, Sequence diversity of Pseudomonas aeruginosa: impact on population structure and genome evolution, J. Bacteriol., 182:, 3125, 10.1128/JB.182.11.3125-3135.2000 · DOI · Paper page
  32. Kounnas, 1992, The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A, J. Biol. Chem., 267:, 12420, 10.1016/S0021-9258(18)42291-0 · DOI · Paper page
  33. Lau, 2004, The role of pyocyanin in Pseudomonas aeruginosa infection, Trends Mol. Med., 10:, 599, 10.1016/j.molmed.2004.10.002 · DOI · Paper page
  34. Leach, 1993, Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer, Cell., 75:, 1215, 10.1016/0092-8674(93)90330-S · DOI · Paper page
  35. LeClerc, 1996, High mutation frequencies among Escherichia coli and Salmonella pathogens, Science., 274:, 1208, 10.1126/science.274.5290.1208 · DOI · Paper page
  36. Lieberman, 2003, Pseudomonal infections in patients with COPD: epidemiology and management, Am.J. Respir. Med., 2:, 459, 10.1007/BF03256673 · DOI
  37. Livermore, 2002, Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?, Clin. Infect. Dis., 34:, 634, 10.1086/338782 · DOI · Paper page
  38. Lujan, 2007, Quorom-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain, Microbiology., 153:, 225, 10.1099/mic.0.29021-0 · DOI · Paper page
  39. Lynch, 2001, Hospital-acquired pneumonia: risk factors, microbiology, and treatment, Chest., 119, 373, 10.1378/chest.119.2_suppl.373S · DOI · Paper page
  40. Macia, 2005, Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections, Antimicrob. Agents Chemother., 49:, 3382, 10.1128/AAC.49.8.3382-3386.2005 · DOI · Paper page
  41. Macia, 2004, Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion, Antimicrob. Agents Chemother., 48:, 2665, 10.1128/AAC.48.7.2665-2672.2004 · DOI
  42. Maciá, 2006, Efficacy and potential for resistance selection of anti-pseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 50:, 975, 10.1128/AAC.50.3.975-983.2006 · DOI
  43. Mah, 2001, Mechanisms of biofilm resistance to antimicrobial agents, Trends Microbiol., 9:, 34, 10.1016/S0966-842X(00)01913-2 · DOI · Paper page
  44. Mahenthiralingam, 1994, Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis, Infect. Immun., 62:, 596, 10.1128/IAI.62.2.596-605.1994 · DOI · Paper page
  45. Mao, 1997, Proliferation of mutators in a cell population, J. Bacteriol., 179:, 417, 10.1128/JB.179.2.417-422.1997 · DOI · Paper page
  46. Mariencheck, 2003, Pseudomonas aeruginosa elastase degrades surfactant proteins A and D, Am. J. Respir. Cell Mol. Biol., 28:, 528, 10.1165/rcmb.2002-0141OC · DOI · Paper page
  47. Matic, 1997, High variable mutation rates in commensal and pathogenic Escherichia coli, Science., 277:, 1833, 10.1126/science.277.5333.1833 · DOI · Paper page
  48. Matic, 1995, Interspecies gene exchange in bacteria: the role of SOS and mismatch repair systems in evolution of species, Cell., 80:, 507, 10.1016/0092-8674(95)90501-4 · DOI · Paper page
  49. Mena, 2007, Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice, J. Bacteriol, 189:, 3665, 10.1128/JB.00120-07 · DOI
  50. Meyer, 1996, Pyoverdin is essential for virulence of Pseudomonas aeruginosa, Infect. Immun., 64:, 518, 10.1128/IAI.64.2.518-523.1996 · DOI · Paper page
  51. Miller, 1996, Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair, Annu. Rev. Microbiol., 50:, 625, 10.1146/annurev.micro.50.1.625 · DOI · Paper page
  52. Montanari, 2007, Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis, Microbiology., 153:, 1445, 10.1099/mic.0.2006/003400-0 · DOI · Paper page
  53. Moyano, 2007, MutS deficiency and activity of the error-prone DNA polymerase IV are crucial for determining mucA as the main target for mucoid conversion in Pseudomonas aeruginosa, Mol. Microbiol., 64:, 547, 10.1111/j.1365-2958.2007.05675.x · DOI
  54. Nagaki, 1992, Role of chronic Pseudomonas aeruginosa infection in the development of bronchiectasis, Chest., 102:, 1464, 10.1378/chest.102.5.1464 · doi:10.1378/chest.102.5.1464
  55. Nicotra, 1995, Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort, Chest., 108:, 955, 10.1378/chest.108.4.955 · DOI · Paper page
  56. Oliver, 2002, The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants, Mol. Microbiol., 43:, 1641, 10.1046/j.1365-2958.2002.02855.x · DOI · Paper page
  57. Oliver, 2000, High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection, Science., 288:, 1251, 10.1126/science.288.5469.1251 · DOI · Paper page
  58. Oliver, 2004, Hypermutation and the pre-existence of antibiotic resistance Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections, Antimicrob. Agents Chemother., 48:, 4226, 10.1128/AAC.48.11.4226-4233.2004 · DOI
  59. Oliver, 1985, The effect of Pseudomonas aeruginosa alginate on rat alveolar macrophage phagocytosis and bacterial opsonization, Clin. Exp. Immunol., 59:, 190
  60. Parad, 1999, Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype, Infect. Immun., 67:, 4744, 10.1128/IAI.67.9.4744-4750.1999 · DOI
  61. Pedersen, 1990, Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflamatory response, Infect. Immun., 58:, 3363, 10.1128/IAI.58.10.3363-3368.1990 · DOI · Paper page
  62. Pier, 1996, Role of mutant CFTR in hypersusceptibility of cystic fibrosis to lung infections, Science., 271:, 64, 10.1126/science.271.5245.64 · DOI · Paper page
  63. Pirnay, 2002, Pseudomonas aeruginosa displays an epidemic population structure, Environ. Microbiol., 4:, 898, 10.1046/j.1462-2920.2002.00321.x · DOI
  64. Prunier, 2003, High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains, J. Infect. Dis., 187:, 1709, 10.1086/374937 · DOI · Paper page
  65. Rainey, 1998, Adaptive radiation in a heterogeneous environment, Nature., 394:, 69, 10.1038/27900 · DOI · Paper page
  66. Román, 2004, Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains, J. Clin. Microbiol., 42:, 1450, 10.1128/JCM.42.4.1450-1459.2004 · DOI
  67. Romling, 1994a, Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis, J. Infect. Dis., 170:, 1616, 10.1093/infdis/170.6.1616 · DOI · Paper page
  68. Römling, 1994b, A major Pseudomonas aeruginosa clone common to patients and aquatic habitats, Appl. Environ. Microbiol., 60:, 1734, 10.1128/AEM.60.6.1734-1738.1994 · DOI · Paper page
  69. Salyers, 2002, Pseudomonas aeruginosa and related species, a lesson of versatility,, 247
  70. Sato, 2004, ExoU is a potent intracellular phospholipase, Mol. Microbiol., 53:, 1279, 10.1111/j.1365-2958.2004.04194.x · DOI · Paper page
  71. Silo-Suh, 2005, Adaptations of Pseudomonas aeruginosa to the cystic fibrosis lung environment can include deregulation of zwf, encoding glucose-6-phosphate dehydrogenase, J. Bacteriol., 187:, 7561, 10.1128/JB.187.22.7561-7568.2005 · doi:10.1128/jb.187.22.7561-7568.2005
  72. Simpson, 1989, Scavenging by alginate of free radicals released by macrophages, Free Radic. Biol. Med., 6:, 347, 10.1016/0891-5849(89)90078-6 · DOI · Paper page
  73. Smania, 2004, Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa, Microbiology., 150:, 1327, 10.1099/mic.0.26751-0 · DOI
  74. Spencer, 2003, Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa, J. Bacteriol., 185:, 1316, 10.1128/JB.185.4.1316-1325.2003 · DOI · Paper page
  75. Stover, 2000, Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen, Nature., 406:, 959, 10.1038/35023079 · DOI · Paper page
  76. Taddei, 1997, Role of mutator alleles in adaptive evolution, Nature., 387:, 700, 10.1038/42696 · DOI · Paper page
  77. Taylor, 1993a, Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa, Thorax., 48:, 1002, 10.1136/thx.48.10.1002 · doi:10.1136/thx.48.10.1002
  78. Taylor, 1993b, Auxotrophic mutants of Pseudomonas aeruginosa: increased resistance to antipseudomonal antibiotics in cystic fibrosis, Med. Microbiol. Lett., 2:, 25
  79. Ventre, 2006, Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes, Proc. Natl. Acad. Sci. USA., 103:, 171, 10.1073/pnas.0507407103 · DOI · Paper page
  80. Vincent, 2003, Nosocomial infections in adult intensive-care units, Lancet., 361:, 2068, 10.1016/S0140-6736(03)13644-6 · DOI · Paper page
  81. Whiteley, 2001, Gene expression in Pseudomonas aeruginosa biofilms, Nature., 413:, 860, 10.1038/35101627 · DOI · Paper page
  82. Wilson, 1997, Effect of sputum bacteriology on the quality of life of patients with bronchiectasis, Eur. Respir. J., 10:, 1754, 10.1183/09031936.97.10081754 · DOI · Paper page
  83. Yahr, 1998, ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system, Proc. Natl. Acad. Sci. USA., 95:, 13899, 10.1073/pnas.95.23.13899 · DOI · Paper page
  84. Yoon, 2002, Pseudomonas aeruginosa anaerobic respiration in biofilms, Dev. Cell., 3:, 593, 10.1016/S1534-5807(02)00295-2 · DOI · Paper page
  85. Yu, 1998, Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge, Infect. Immun., 66:, 280, 10.1128/IAI.66.1.280-288.1998 · DOI

Cited by

See all 8

Metadata

Authors
Oliver, A., Mena, A., & Maciá, M. D.
Affiliations
Servicio de Microbiología; Hospital Son Dureta; Palma de Mallorca Spain
Venue
Evolutionary Biology of Bacterial and Fungal Pathogens
Publisher
ASM Press
Published
2014-04-30
Pages
433-444
Cited by
8
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evolution of Pseudomonas aeruginosa Pathogenicity: From Acute to Chronic Infections. https://app.cochat.ai/papers/10.1128/9781555815639.ch36
The paper
Oliver, A., Mena, A., & Maciá, M. D. (2014). Evolution of Pseudomonas aeruginosa Pathogenicity: From Acute to Chronic Infections. Evolutionary Biology of Bacterial and Fungal Pathogens. https://doi.org/10.1128/9781555815639.ch36

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.